{"text": ["AbbVie", "Partners", "With", "I-Mab", "for", "Cancer", "Drug"], "created_at": "2020-09-04 17:41:00"}
{"text": ["AbbVie", "Inks", "$2.9", "Billion", "Cancer", "Deal", "With", "China\u2019s", "I-Mab"], "created_at": "2020-09-04 14:26:48"}
{"text": ["A", "Look", "Into", "AbbVie's", "Debt"], "created_at": "2020-09-04 14:08:43"}
{"text": ["AbbVie", "Partners", "With", "I-Mab", "for", "Cancer", "Treatment", "Candidate"], "created_at": "2020-09-04 14:07:00"}
{"text": ["I-Mab's", "stock", "soars", "after", "AbbVie", "collaboration,", "which", "could", "be", "worth", "nearly", "$2", "billion"], "created_at": "2020-09-04 11:50:00"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "AbbVie", "In-licenses", "I-Mab's", "Cancer", "Drug,", "Savara", "Pulls", "The", "Plug", "On", "Cystic", "Fibrosis", "Study"], "created_at": "2020-09-04 11:28:02"}
{"text": ["Like", "Dividends?", "I", "Bet", "You'll", "Love", "These", "2", "Stocks"], "created_at": "2020-09-04 11:15:00"}
{"text": ["AbbVie", "and", "I-Mab", "Enter", "Into", "Global", "Strategic", "Partnership", "for", "Differentiated", "Immuno-oncology", "Therapy"], "created_at": "2020-09-04 11:00:00"}
